GENE ONLINE|News &
Opinion
Blog

2026-04-28|

UCLA Researchers Develop SEE-CITE Technology to Precisely Map Small Molecule Binding Sites on Proteins

by GOAI
Share To

Researchers at UCLA have introduced a new technology called SEE-CITE, which significantly improves the ability to identify where small molecules bind to proteins. This advancement builds on an existing method known as photo-crosslinking and allows scientists to map these binding sites with greater precision and reliability. The development has potential implications for accelerating drug discovery and advancing molecular biology research.

The SEE-CITE technology refines the process of photo-crosslinking by enhancing its accuracy in pinpointing interactions between small molecules and proteins. This capability is critical for understanding how drugs interact with their targets at a molecular level, which can inform the design of more effective therapies. Researchers describe this approach as a step forward in addressing challenges associated with studying complex biological systems.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: April 28, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
Ellomay Capital Completes Sale of Dorad Energy Holdings on May 10, 2026
2026-05-10
Digitalis Glycosides Studied for Heart Failure Treatment at ESC Heart Failure 2026 Congress
2026-05-10
Digoxin Lowers Death Risk and Heart Failure in Rheumatic Heart Disease Patients, Study Finds
2026-05-10
New Test Detects Biomarkers for Frontotemporal Lobar Degeneration, a Rare Dementia Affecting Over 57 Million Globally
2026-05-10
India’s Pharmaceutical Growth Slows: Industry Needs New Strategies
2026-05-10
MoonLake Immunotherapeutics Concludes Pre-BLA Meeting with FDA and Reports Q1 2026 Financial Results
2026-05-10
New Method Allows Repeated Genetic Data Extraction From Living Cells Without Destruction
2026-05-10
Scroll to Top